论文部分内容阅读
一、化学疗法 1.新的抗癌药最近,新的抗癌药的开发,主要是向着减轻副作用的方向努力。即对过去的抗癌药进行化学修饰,保留效果,减少副作用。①顺铂(CDDP)和其类似化合物顺铂抗癌作用强,抗癌谱也广,所以已把它作为各种脏器癌采用和并用疗法的中心药物之一。有报告抗癌药无效的胃癌,用EAP疗法(鬼臼乙叉甙、阿霉素、顺铂)或EP疗法(5-氟脲嘧啶、顺铂)有很高的疗效。但是,另一方面,肾损害、消化器官损害等副作用也较大,而且是多种多样的。为减轻副作用,特别是减轻肾毒性,正在大力开发carboplatin(CBDCA)、iproplatin(CHIP)、254-S、DWA、NK
First, Chemotherapy 1. New anti-cancer drugs Recently, the development of new anti-cancer drugs has been mainly aimed at reducing side effects. That is, chemical modification of past anticancer drugs will preserve the effect and reduce side effects. 1 Cisplatin (CDDP) and its analogous compound cisplatin have a strong anti-cancer effect and a broad spectrum of anticancer drugs, so it has been used as one of the central drugs for various organ cancers and combination therapies. There are reports of gastric cancer in which anti-cancer drugs are ineffective, and use EAP therapy (Erythropoietin, Adriamycin, Cisplatin) or EP therapy (5-fluorouracil, cisplatin) for high efficacy. However, on the other hand, kidney damage, digestive organ damage and other side effects are also large and varied. In order to reduce side effects, especially to reduce nephrotoxicity, carboplatin (CBDCA), iproplatin (CHIP), 254-S, DWA, NK are being vigorously developed.